Sectoral Asset Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Sectoral Asset Management’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-22,500	Closed	-$343K	–	101
2024 Q2	$343K	Sell	22,500 -5,000	-18%	-$71.7K	0.14%	79
2024 Q1	$403K	Buy	27,500 +5,000	+22%	+$73K	0.16%	78
2023 Q4	$313K	Hold	22,500	–	–	0.13%	91
2023 Q3	$301K	Sell	22,500 -17,520	-44%	-$237K	0.06%	114
2023 Q2	$505K	Hold	40,020	–	–	0.08%	106
2023 Q1	$456K	Sell	40,020 -10,000	-20%	-$108K	0.09%	103
2022 Q4	$518K	Buy	50,020 +5,000	+11%	+$53.9K	0.1%	101
2022 Q3	$471K	Buy	45,020 +2,500	+6%	+$26.6K	0.09%	91
2022 Q2	$471K	Buy	42,520 +17,500	+70%	+$190K	0.09%	96
2022 Q1	$279K	Buy	25,020 +10,000	+67%	+$113K	0.05%	105
2021 Q4	$196K	Sell	15,020 -17,250	-53%	-$217K	0.03%	107
2021 Q3	$420K	Hold	32,270	–	–	0.03%	120
2021 Q2	$474K	Hold	32,270	–	–	0.04%	115
2021 Q1	$396K	Hold	32,270	–	–	0.03%	107
2020 Q4	$460K	Buy	32,270 +5,500	+21%	+$74.1K	0.03%	93
2020 Q3	$372K	Sell	26,770 -10,000	-27%	-$119K	0.03%	87
2020 Q2	$390K	Hold	36,770	–	–	0.04%	148
2020 Q1	$297K	Sell	36,770 -41,000	-53%	-$342K	0.06%	65
2019 Q4	$631K	Sell	77,770 -119,215	-61%	-$941K	0.09%	63
2019 Q3	$1.49M	Hold	196,985	–	–	0.26%	56
2019 Q2	$1.48M	Buy	196,985 +98,500	+100%	+$774K	0.18%	64
2019 Q1	$798K	Buy	98,485 +8,000	+9%	+$60.8K	0.1%	73
2018 Q4	$682K	Sell	90,485 -17,500	-16%	-$123K	0.09%	65
2018 Q3	$747K	Hold	107,985	–	–	0.08%	77
2018 Q2	$695K	Sell	107,985 -19,495	-15%	-$123K	0.08%	66
2018 Q1	$833K	Hold	127,480	–	–	0.09%	67
2017 Q4	$958K	Sell	127,480 -101,500	-44%	-$731K	0.12%	66
2017 Q3	$1.63M	Buy	228,980 +133,655	+140%	+$961K	0.21%	58
2017 Q2	$803K	Sell	95,325 -65,450	-41%	-$532K	0.09%	60
2017 Q1	$1.29M	Hold	160,775	–	–	0.15%	55
2016 Q4	$1.46M	Hold	160,775	–	–	0.16%	45
2016 Q3	$1.49M	Hold	160,775	–	–	0.15%	54
2016 Q2	$1.65M	Sell	160,775 -299,750	-65%	-$2.75M	0.17%	53
2016 Q1	$4.16M	Sell	460,525 -147,405	-24%	-$1.32M	0.2%	61
2015 Q4	$5.63M	Sell	607,930 -666,575	-52%	-$7.3M	0.24%	53
2015 Q3	$16.3M	Buy	1,274,505 +35,935	+3%	+$446K	0.75%	34
2015 Q2	$13.7M	Sell	1,238,570 -3,406,240	-73%	-$37.6M	0.57%	45
2015 Q1	$53M	Buy	4,644,810 +829,965	+22%	+$8.8M	2.01%	16
2014 Q4	$38.5M	Buy	3,814,845 +140,110	+4%	+$1.47M	1.73%	20
2014 Q3	$38.6M	Buy	3,674,735 +1,125,150	+44%	+$10.6M	1.63%	21
2014 Q2	$22M	Buy	2,549,585 +391,525	+18%	+$3.29M	0.93%	33
2014 Q1	$18.9M	Sell	2,158,060 -12,890	-0.6%	-$112K	0.78%	39
2013 Q4	$17.8M	Sell	2,170,950 -40,750	-2%	-$323K	0.77%	42
2013 Q3	$16.7M	Buy	2,211,700 +19,500	+0.9%	+$142K	0.8%	37
2013 Q2	$16.6M	Buy	+2,192,200	New	+$16M	0.49%	40

Other funds holding RDY

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $70.2B AUM 29.99% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Sectoral Asset Management's RDY Position: Q3 2024 in Review

Sectoral Asset Management sold out of Dr. Reddy's Laboratories (RDY) in Q3 2024, closing a stake of 22,500 shares — an estimated $343K sold.

Sectoral Asset Management first reported a position in RDY in Q2 2013 and held it in 45 quarters. The position peaked at $53M in Q1 2015. 227 funds tracked by Wall St. Rank hold RDY as of Q3 2024.

Sectoral Asset Management reported no remaining Dr. Reddy's Laboratories position as of Q3 2024 after selling out during the quarter.
Sectoral Asset Management sold 22,500 Dr. Reddy's Laboratories shares in Q3 2024, an estimated $343K.
Sectoral Asset Management first reported a position in Dr. Reddy's Laboratories in Q2 2013 and held it in 45 quarters.
Sectoral Asset Management's Dr. Reddy's Laboratories position peaked at $53M in Q1 2015.
227 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2024.

Based on Sectoral Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.